In trials to assess semaglutides effectiveness for reducing the risk of major cardiovascular events in adults, more people taking Wegovy developed kidney stones than those on placebo 1.2% vs 0.8% respectively
(2022, June 17)
and (3) Primary and secondary outcomes as predefined (e.g., CV death, MACE, expanded MACE, nonfatal MI, nonfatal stroke, hospitalization for HF, SBP/DBP, LDL/HDL, eGFR, and UACR)
TB-500 gets the most scrutiny because Thymosin Beta-4 appears at elevated levels in some cancer cell lines
With an initial focus on weight-management solutions, Whole Health Rx is offering virtual, streamlined access to GLP-1 agonist medications such as Ozempic, Mounjaro, Rybelsus and compounded versions of semaglutide and tirzepatide via licensed medical providers